Barrington Research reiterated its Volcano VOLC Outperform rating and $31 price target in a research report published today.
In the report, Barrington Research states, "We are reiterating our OUTPERFORM rating and $31 price target based on our belief that the clinical evidence is building for VOLC's IVUS and FM technology to be standard of care for a large percentage of the millions of worldwide PCI procedures."
Shares of Volcano were trading at $28.84 at the time of posting, up 2.27% from Friday's market close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in